Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review
Among the health-promotional protein-based vehicles, bovine serum albumin nanoparticles
(BSA NPs) are particularly interesting. Meeting requirements eg, non-toxicity, non …
(BSA NPs) are particularly interesting. Meeting requirements eg, non-toxicity, non …
Polysaccharide-based nanocarriers for efficient transvascular drug delivery
M Zhang, H Ma, X Wang, B Yu, H Cong… - Journal of Controlled …, 2023 - Elsevier
Polysaccharide-based nanocarriers (PBNs) are the focus of extensive investigation because
of their biocompatibility, low cost, wide availability, and chemical versatility, which allow a …
of their biocompatibility, low cost, wide availability, and chemical versatility, which allow a …
Current trends in the use of human serum albumin for drug delivery in cancer
Introduction Human serum albumin is the most abundant transport protein in plasma, which
has recently been extensively utilized to form nanoparticles for drug delivery in cancer. The …
has recently been extensively utilized to form nanoparticles for drug delivery in cancer. The …
Lipid, polymeric, inorganic-based drug delivery applications for platinum-based anticancer drugs
The three main FDA-approved platinum drugs in chemotherapy such as carboplatin,
cisplatin, and oxaliplatin are extensively applied in cancer treatments. Although the clinical …
cisplatin, and oxaliplatin are extensively applied in cancer treatments. Although the clinical …
Hybrid protein-polymer nanoparticles based on P (NVCL-co-DMAEMA) loaded with cisplatin as a potential anti-cancer agent
DB Viana, M Mathieu-Gaedke, NM Leão… - Journal of Drug Delivery …, 2023 - Elsevier
Responsive polymers are a promising class of materials for a variety of applications,
especially for the construction of biomedical devices such as novel drug delivery systems. In …
especially for the construction of biomedical devices such as novel drug delivery systems. In …
Quantum chemical study of 2-hydroxypropyl-β-cyclodextrin and genipin-crosslinked chitosan nanocarriers functionalized with cytarabine anticancer drug
Drug delivery systems based on ring-like nanocarriers such as 2-hydroxypropyl-β-
cyclodextrin (HP-β-CD) and genipin-crosslinked chitosan (GCS) are increasingly used in the …
cyclodextrin (HP-β-CD) and genipin-crosslinked chitosan (GCS) are increasingly used in the …
Circumventing Physicochemical Barriers of Cyclometalated Gold (III) Dithiocarbamate Complexes with Protein-Based Nanoparticle Delivery to Enhance Anticancer …
AS Arojojoye, B Walker, JC Dawahare… - … Applied Materials & …, 2023 - ACS Publications
Optimizing the bioavailability of drug candidates is crucial to successful drug development
campaigns, especially for metal-derived chemotherapeutic agents. Nanoparticle delivery …
campaigns, especially for metal-derived chemotherapeutic agents. Nanoparticle delivery …
β-cyclodextrin-lenalidomide anticancer drug delivery nanosystem: A quantum chemical approach
H Harati, A Morsali, MR Bozorgmehr… - Journal of Molecular …, 2021 - Elsevier
Abstract β-cyclodextrin (β-CD) has been widely used as a nanocarrier for anticancer drugs
due to its convenient shape and size. The therapeutic agents can be loaded into the cavity …
due to its convenient shape and size. The therapeutic agents can be loaded into the cavity …
Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects
R Liu, W Hou, J Li, X Gou, M Gao, H Wang… - International Journal of …, 2024 - Elsevier
Abstract Treatment for triple negative breast cancer (TNBC) remains a huge challenge due
to the lack of targeted therapeutics and tumor heterogenicity. Cisplatin (Cis) have …
to the lack of targeted therapeutics and tumor heterogenicity. Cisplatin (Cis) have …
Human epidermal growth factor receptor 2 (Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment …
Q Jia, F Li, C Li, C Guo, S Wu, L Hao, Z Li - Drug Delivery and …, 2024 - Springer
Undifferentiated thyroid cancer (ATC) is highly malignant and does not respond well to
sorafenib (SRF) treatment owing to the lack of specificity of SRF targeting. Drug delivery …
sorafenib (SRF) treatment owing to the lack of specificity of SRF targeting. Drug delivery …